Conmed (CNMD) Other Non-Current Assets (2010 - 2026)

Conmed has reported Other Non-Current Assets for 17 years, with the latest figure at $151.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 19.38% year-over-year to $151.7 million; the trailing twelve-month figure through Mar 2026 stood at $151.7 million (up 19.38% YoY), and the FY2025 full-year result was $150.5 million, up 29.34% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $151.7 million, up from $150.5 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $151.7 million in Q1 2026, with the low at $93.9 million in Q4 2022.
• Historically, Other Non-Current Assets has averaged $117.9 million across 5 years, with a median of $108.0 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets retreated 4.98% — and 2025, when it jumped 37.84%.
• Conmed's Other Non-Current Assets stood at $93.9 million in 2022, then advanced by 2.38% to $96.1 million in 2023, then gained by 21.07% to $116.4 million in 2024, then gained by 29.34% to $150.5 million in 2025, then grew by 0.82% to $151.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $151.7 million (Q1 2026), $150.5 million (Q4 2025), and $148.3 million (Q3 2025), per Business Quant data.